Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock

Critical Care Medicine

Volumn 33, Issue 3, 2005, Pages 629-637

  Kubulus, Darius ^a   Rensing, Hauke ^a   Paxian, Markus ^a   Thierbach, Jan Tobias ^b   Meisel, Tanja ^b   Redl, Heinz ^c   Bauer, Michael ^a   Bauer, Inge ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Diaspirin cross linked hemoglobin; Heme oxygenase 1; Hemin arginate; Hemoglobin glutamer; Hemoglobin based oxygen carrier

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEME DERIVATIVE; HEME OXYGENASE 1; HEMIN ARGINATE; HEMOGLOBIN GLUTAMER 200; MESOPORPHYRIN TIN; MESOPORPHYRIN TIN IX; RINGER SOLUTION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL PRESSURE; ARTICLE; BLEEDING; BLOOD VOLUME; BODY WEIGHT; CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ENZYME ACTIVITY; EXPERIMENT; HEART; HEMORRHAGIC SHOCK; KIDNEY; LABORATORY; LIVER; LIVER CELL; LUNG; MALE; MEASUREMENT; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTECTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RESUSCITATION; TIME; UNIVERSITY HOSPITAL;

ANIMALS; ASPIRIN; BLOOD SUBSTITUTES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEMIN; HEMOGLOBINS; HSP70 HEAT-SHOCK PROTEINS; LIVER; LIVER FAILURE; MALE; PROSPECTIVE STUDIES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; SURVIVAL ANALYSIS;

EID: 14944356009     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000156295.48075.49     Document Type: Article

References (46)

1. Carrico CJ, Holcomb JB, Chaudry IH: Scientific priorities and strategic planning for resuscitation research and life saving therapy following traumatic injury: Report of the PULSE Trauma Work Group. Shock 2002; 17:165-168
2. Paxian M, Rensing H, Geckeis K, et al: Perflubron emulsion in prolonged hemorrhagic shock: Influence on hepatocellular energy metabolism and oxygen-dependent gene expression. Anesthesiology 2003; 98:1391-1399
3. Keipert PE, Faithfull NS, Roth DJ, et al: Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier. Adv Exp Med Biol 1996; 388:603-609
4. Kothe N, Eichentopf B, Bonhard K: Characterization of a modified, stroma-free hemoglobin solution as an oxygen-carrying plasma substitute. Surg Gynecol Obstet 1985; 161:563-569
5. Lamy ML, Daily EK, Brichant JF, et al: Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology 200092:646-656 92: 646-656
6. Mondoro TH, Alayash AI, Ryan BA, et al: Hemoglobin A0 and alpha-crosslinked hemoglobin (alpha-DBBF) potentiate agonist-induced platelet aggregation through the platelet thromboxane receptor. Artif Cells Blood Substit Immobil Biotechnol 1998; 26:1-16
7. Chang TM, Lister C, Nishiya T, et al: Immunological effects of hemoglobin, encapsulated hemoglobin, polyhemoglobin and conjugated hemoglobin using different immunization schedules. Biomater Artif Cells Immobilization Biotechnol 1992; 20:611-618
8. Everse J, Hsia N: The toxicities of native and modified hemoglobins. Free Radic Biol Med 1997; 22:1075-1099
9. Hess JR, Macdonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74:1769-1778
10. Winslow RM: Current status of blood substitute research: Towards a new paradigm. J Intern Med 2003; 253:508-517
11. Winslow RM: Alpha-alpha-crosslinked hemoglobin: Was failure predicted by preclinical testing? Vox Sang 2000; 79:1-20
12. Sloan EP, Koenigsberg M, Gens D, et al: Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. JAMA 1999; 282:1857-1864
13. Saxena R, Wijnhoud AD, Carton H, et al: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30:993-996
14. Mustajoki P, Nordmann Y: Early administration of heme arginate for acute porphyric attacks. Arch Intern Med 1993; 153: 2004-2008
15. Mustajoki P, Tenhunen R, Tokola O, et al: Haem arginate in the treatment of acute hepatic porphyrias. BMJ (Clin Res Ed) 1986; 293:538-539
16. Tenhunen R, Tokola O, Linden IB: Haem arginate: A new stable haem compound. J Pharm Pharmacol 1987; 39:780-786
17. Martasek P, Schwartzman ML, Goodman AI, et al: Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J Am Soc Nephrol 1991; 2:1078-1084
18. Tenhunen R, Marver HS, Schmid R: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 1968; 61:748-755
19. Stocker R, Yamamoto Y, McDonagh AF, et al: Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043-1046
20. Bauer M: Heme oxygenase in liver transplantation: Heme catabolism and metabolites in the search of function. Hepatology 2003; 38:286-288
21. Rensing H, Bauer I, Datene V, et al: Differential expression pattern of heme oxygenase-1/heat shock protein 32 and nitric oxide synthase-II and their impact on liver injury in a rat model of hemorrhage and resuscitation. Crit Care Med 1999; 27:2766-2775
22. Guide for the Care and Use of Laboratory Animals (DHEW Publication No. NIH 86-23). Bethesda, MD, National Institutes of Health, 1985
23. Walter MI, Gerarde HW: An ultramicromethod for the determination of conjugated and total bilirubin in serum or plasma. Microchem J 1970; 15:231
24. Clemens MG, Bauer M, Pannen BH, et al: Remodeling of hepatic microvascular responsiveness after ischemia/reperfusion. Shock 1997; 8:80-85
25. Burhop KE, Estep TE: Hemoglobin-induced myocardial lesions. Artif Cells Blood Substit Immobil Biotechnol 2001; 29:101
26. Schubert A, O'Hara JF Jr, Przybelski RJ, et al: Effect of diaspirin crosslinked hemoglobin (DCLHb HemAssist) during high blood loss surgery on selected indices of organ function. Artif Cells Blood Substit Immobil Biotechnol 2002; 30:259-283
27. Alayash AI: Hemoglobin-based blood substitutes: Oxygen carriers, pressor agents, or oxidants? Nat Biotechnol 1999; 17:545-549
28. Olson JS, Foley EW, Rogge C, et al: No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004; 36:685-697
29. Maruhashi K, Kasahara Y, Ohta K, et al: Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase-1 in an anchorage-dependent cell ECV304. J Cell Biochem 2004; 93:552
30. Suttner DM, Dennery PA: Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 1999; 13:1800-1809
31. Winslow RM: New transfusion strategies: Red cell substitutes. Annu Rev Med 1999; 50:337-353
32. Bauer I, Wanner GA, Rensing H, et al: Expression pattern of heme oxygenase isoenzymes 1 and 2 in normal and stress-exposed rat liver.Hepatology 1998; 27:829-838
33. Shibahara S, Yoshida T, Kikuchi G: Induction of heme oxygenase by hemin in cultured pig alveolar macrophages. Arch Biochem Biophys 1978; 188:243-250
34. Liu X, Yang C, He X: Expression of HO-1 in chronic renal insufficiency. Rat kidney and implication. J Huazhong Univ Sci Technolog Med Sci 2003; 23:271-274
35. Balla J, Vercellotti GM, Nath K, et al: Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 2003; 18(Suppl 5):v8-v12
36. Sharp FR, Kinouchi H, Koistinaho J, et al: HSP70 heat shock gene regulation during ischemia. Stroke 1993; 24:172-175
37. York GB, Eggers JS, Smith DL, et al: Low-volume resuscitation with a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) provides adequate tissue oxygenation for survival in a porcine model of controlled hemorrhage. J Trauma 2003; 55:873-885
38. Sprung J, Kindscher JD, Wahr JA, et al: The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: Results of a multicenter, randomized, single-blinded trial. Anesth Analg 2002; 94:799-808
39. Levy JH: The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Expert Opin Biol Ther 2003; 3:509-517
40. Tokola O, Tenhunen R, Volin L, et al: Pharmacokinetics of intravenously administered haem arginate. Br J Clin Pharmacol 1986; 22:331-335
41. Keipert PE, Gomez CL, Gonzales A, et al: Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 1994; 123:701-711
42. Bauer M, Bauer I: Heme oxygenase-1: Redox regulation and role in the hepatic response to oxidative stress. Antioxid Redox Signal 2002; 4:749-758
43. Kubulus D, Roesken F, Amon M, et al: The mechanism of the delay phenomenon: Tissue protection is mediated by heme oxygenase-1. Am J Physiol Heart Circ Physiol 2004; 287:H2332-H2340
44. Kume M, Yamamoto Y, Saad S, et al: Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996; 128:251-258
45. Riess ML, Stowe DF, Warltier DC: Cardiac pharmacological preconditioning with volatile anesthetics: From bench to bedside? Am J. Physiol Heart Circ Physiol 2004; 286:H1603-H1607
46. Chen YH, Yet SF, Perrella MA: Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp Biol Med (Maywood) 2003; 228:447-453